Myriad (MYGN) Issues Response to Supreme Court Decision on Gene Patent
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.58 +0.04 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.54 | 52 Week High | $45.34 | |||
| Open | $4.51 | 52 Week Low | $15.92 | |||
| Day High | $4.62 | P/E | 1.97 | |||
| Day Low | $4.41 | EPS | $2.33 | |||
| Volume | 2,759,837 | |||||
